DrugUse-v1.2.2(2015EN): verschil tussen versies

Uit Zorginformatiebouwstenen
Ga naar: navigatie, zoeken
(Nieuwe pagina aangemaakt met '==General information== Name: '''nl.nfu.DrugUse''' link=DrugsGebruik-v1.2.2(2015NL)<BR> Version: '''1.2.2''' <br> HCIM Status:Final<br> Publi...')
 
 
(3 tussenliggende versies door dezelfde gebruiker niet weergegeven)
Regel 1: Regel 1:
==General information==
+
<!-- Hieronder wordt een transclude page aangeroepen -->
Name: '''nl.nfu.DrugUse''' [[Bestand:NL.png|link=DrugsGebruik-v1.2.2(2015NL)]]<BR>
+
{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.7.4(EN)|1|DrugUse-v1.2.2(2015EN)}}
Version: '''1.2.2''' <br>
+
<!-- Tot hier de transclude page -->
HCIM Status:Final<br>
+
==General information<!--hdGeneralInformation-->==
Publication: '''2015''' <br>
+
Name<!--hdName-->: '''nl.nfu.DrugUse''' [[Bestand:NL.png|link=DrugsGebruik-v1.2.2(2015NL)]]<BR>
Release status: Published<br>
+
Version<!--hdVersion-->: '''1.2.2''' <br>
Publication date: 1-4-2015
+
HCIM Status<!--hdStatus-->:Final<br>
 +
Release<!--hdPublication-->: '''2015''' <br>
 +
Release status<!--hdPublicationStatus-->: Published<br>
 +
Release date<!--hdPublicationDate-->: 1-4-2015
 
-----
 
-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2015(EN)]] [[HCIM_Release_2015(EN) |Back to HCIM list ]]</div>
+
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release<!--wikiReleasePage-->_2015(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2015(EN) |Back to HCIM list<!--hdBackToMainPage--> ]]</div>
  
 
==Metadata==
 
==Metadata==
Regel 61: Regel 64:
 
==Revision History==
 
==Revision History==
 
<div class="mw-collapsible mw-collapsed">
 
<div class="mw-collapsible mw-collapsed">
''Only available in Dutch''
+
''Only available in Dutch<!--noTranslation-->''
  
 
<u>Publicatieversie 1.0</u> (15-02-2013)
 
<u>Publicatieversie 1.0</u> (15-02-2013)
Regel 161: Regel 164:
 
==Information Model==
 
==Information Model==
 
<BR>
 
<BR>
[[Bestand: DrugUse-v1.2.2Model(EN).png | center]]
+
<imagemap> Bestand:DrugUse-v1.2.2Model(2015EN).png | center  
 +
rect 525 247 670 317 [[#11349]]
 +
rect 702 257 879 307 [[#RouteOfAdministrationCodelist]]
 +
rect 702 157 879 207 [[#DrugUseStatusCodelist]]
 +
rect 357 366 447 436 [[#11356]]
 +
rect 341 241 465 311 [[#11342]]
 +
rect 702 56 902 106 [[#TypeOfDrugOrMedicationCodelist]]
 +
rect 525 145 670 215 [[#11347]]
 +
rect 525 49 670 119 [[#11354]]
 +
rect 176 314 270 384 [[#11335]]
 +
rect 176 216 270 286 [[#11352]]
 +
rect 340 113 464 194 [[#11336]]
 +
rect 176 118 270 188 [[#11333]]
 +
desc none
 +
</imagemap>
 
<BR>
 
<BR>
 
{| border= "1"  width="1500px" style = "font-size: 9.5pt;  border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px"  
 
{| border= "1"  width="1500px" style = "font-size: 9.5pt;  border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px"  
 
|-style="background-color: #1F497D; color: white; font-weight: bold; font-variant: small-caps; "
 
|-style="background-color: #1F497D; color: white; font-weight: bold; font-variant: small-caps; "
|style="width:30px;"|Type||style="width:100px;"|Id||colspan="6 " style="width:140px;"|Concept||Card.||style="width: 600px;"|Definition||style="width:200px;"|DefinitionCode||style="width:200px;"|Reference
+
|style="width:30px;"|Type<!--imType-->||style="width:100px;"|Id<!--imId-->||colspan="6 " style="width:140px;"|Concept<!--imConcept-->||Card.<!--imCard-->||style="width: 600px;"|Definition<!--imDefinition-->||style="width:200px;"|DefinitionCode<!--imDefinitionCode-->||style="width:200px;"|Reference<!--imReference-->
 
|-style="vertical-align:top; background-color: #E3E3E3; "
 
|-style="vertical-align:top; background-color: #E3E3E3; "
|style = "text-align:center" |[[Bestand: block.png| 20px]]
+
|style = "text-align:center" |[[Bestand: block.png| 20px | link=]]
 
||NL-CM:7.4.1
 
||NL-CM:7.4.1
|colspan ="6" style ="padding-left: 0px"|<span Title="NL: DrugsGebruik">[[Bestand: arrowdown.png | 10px]]DrugUse</span>
+
|colspan ="6" style ="padding-left: 0px"|<span Id=11336 Title="NL: DrugsGebruik">[[Bestand: arrowdown.png | 10px | link=]]DrugUse</span>
 
|
 
|
 
|Root concept of the DrugUse building block. This concept contains all data elements of the DrugUse building block.
 
|Root concept of the DrugUse building block. This concept contains all data elements of the DrugUse building block.
Regel 175: Regel 192:
 
|
 
|
 
|-style="vertical-align:top; background-color: #E8D7BE; "
 
|-style="vertical-align:top; background-color: #E8D7BE; "
|style = "text-align:center" |[[Bestand: folder.png| 16px]]
+
|style = "text-align:center" |[[Bestand: folder.png| 16px | link=]]
 
||NL-CM:7.4.5
 
||NL-CM:7.4.5
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: WaarnemingGebruik">[[Bestand: arrowdown.png | 10px]]ObservationOfUse</span>
+
|colspan ="5" style ="padding-left: 0px"|<span Id=11342 Title="NL: WaarnemingGebruik">[[Bestand: arrowdown.png | 10px | link=]]ObservationOfUse</span>
 
|0..1
 
|0..1
 
|Container for ObservationOfUse. This container contains all data elements of the ObservationOfUse container.
 
|Container for ObservationOfUse. This container contains all data elements of the ObservationOfUse container.
Regel 184: Regel 201:
 
|
 
|
 
|-style="vertical-align:top; background-color: transparent; "
 
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: TS.png| 16px]]
+
|style = "text-align:center" |[[Bestand: TS.png| 16px | link=]]
 
||NL-CM:7.4.6
 
||NL-CM:7.4.6
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;" |
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;" |
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="4" style ="padding-left: 0px"|<span Title="NL: StartDatum">[[Bestand: arrowright.png | 10px]]StartDate</span>
+
|colspan ="4" style ="padding-left: 0px"|<span Id=11352 Title="NL: StartDatum">[[Bestand: arrowright.png | 10px | link=]]StartDate</span>
 
|0..1
 
|0..1
 
|The date on which the patient started using.
 
|The date on which the patient started using.
Regel 194: Regel 211:
 
|
 
|
 
|-style="vertical-align:top; background-color: transparent; "
 
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: TS.png| 16px]]
+
|style = "text-align:center" |[[Bestand: TS.png| 16px | link=]]
 
||NL-CM:7.4.7
 
||NL-CM:7.4.7
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;" |
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;" |
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="4" style ="padding-left: 0px"|<span Title="NL: StopDatum">[[Bestand: arrowright.png | 10px]]StopDate</span>
+
|colspan ="4" style ="padding-left: 0px"|<span Id=11335 Title="NL: StopDatum">[[Bestand: arrowright.png | 10px | link=]]StopDate</span>
 
|0..1
 
|0..1
 
|The date on which the patient quit using
 
|The date on which the patient quit using
Regel 204: Regel 221:
 
|
 
|
 
|-style="vertical-align:top; background-color: transparent; "
 
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: ST.png| 16px]]
+
|style = "text-align:center" |[[Bestand: ST.png| 16px | link=]]
 
||NL-CM:7.4.8
 
||NL-CM:7.4.8
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;" |
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: none;" |
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="4" style ="padding-left: 0px"|<span Title="NL: Hoeveelheid">[[Bestand: arrowright.png | 10px]]Amount</span>
+
|colspan ="4" style ="padding-left: 0px"|<span Id=11356 Title="NL: Hoeveelheid">[[Bestand: arrowright.png | 10px | link=]]Amount</span>
 
|0..1
 
|0..1
 
|The number of units (pills, joints, shots etc.) per day, week, month or year or the frequency of use.
 
|The number of units (pills, joints, shots etc.) per day, week, month or year or the frequency of use.
Regel 214: Regel 231:
 
|
 
|
 
|-style="vertical-align:top; background-color: transparent; "
 
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: ST.png| 16px]]
+
|style = "text-align:center" |[[Bestand: ST.png| 16px | link=]]
 
||NL-CM:7.4.9
 
||NL-CM:7.4.9
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: Toelichting">[[Bestand: arrowright.png | 10px]]Explanation</span>
+
|colspan ="5" style ="padding-left: 0px"|<span Id=11333 Title="NL: Toelichting">[[Bestand: arrowright.png | 10px | link=]]Explanation</span>
 
|0..1
 
|0..1
 
|Relevant comments on the drug use.
 
|Relevant comments on the drug use.
Regel 223: Regel 240:
 
|
 
|
 
|-style="vertical-align:top; background-color: transparent; "
 
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px]]
+
|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
 
||NL-CM:7.4.2
 
||NL-CM:7.4.2
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: DrugsOfGeneesmiddelSoort">[[Bestand: arrowright.png | 10px]]TypeOfDrugOrMedication</span>
+
|colspan ="5" style ="padding-left: 0px"|<span Id=11354 Title="NL: DrugsOfGeneesmiddelSoort">[[Bestand: arrowright.png | 10px | link=]]TypeOfDrugOrMedication</span>
 
|0..1
 
|0..1
 
|Type of drug used by the patient.
 
|Type of drug used by the patient.
Regel 233: Regel 250:
 
{|
 
{|
 
|-
 
|-
|[[Bestand: List2.png]]||[[#TypeOfDrugOrMedicationCodelist|TypeOfDrugOrMedicationCodelist]]
+
|[[Bestand: List2.png | link=#TypeOfDrugOrMedicationCodelist]]||[[#TypeOfDrugOrMedicationCodelist|TypeOfDrugOrMedicationCodelist]]
 
|}
 
|}
 
|-style="vertical-align:top; background-color: transparent; "
 
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px]]
+
|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
 
||NL-CM:7.4.3
 
||NL-CM:7.4.3
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: DrugGebruikStatus">[[Bestand: arrowright.png | 10px]]DrugUseStatus</span>
+
|colspan ="5" style ="padding-left: 0px"|<span Id=11347 Title="NL: DrugGebruikStatus">[[Bestand: arrowright.png | 10px | link=]]DrugUseStatus</span>
 
|1
 
|1
 
|Indication stating whether there was any drug use in the past or present.
 
|Indication stating whether there was any drug use in the past or present.
Regel 246: Regel 263:
 
{|
 
{|
 
|-
 
|-
|[[Bestand: List2.png]]||[[#DrugUseStatusCodelist|DrugUseStatusCodelist]]
+
|[[Bestand: List2.png | link=#DrugUseStatusCodelist]]||[[#DrugUseStatusCodelist|DrugUseStatusCodelist]]
 
|}
 
|}
 
|-style="vertical-align:top; background-color: transparent; "
 
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px]]
+
|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
 
||NL-CM:7.4.4
 
||NL-CM:7.4.4
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
 
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: Toedieningsweg">[[Bestand: arrowright.png | 10px]]RouteOfAdministration</span>
+
|colspan ="5" style ="padding-left: 0px"|<span Id=11349 Title="NL: Toedieningsweg">[[Bestand: arrowright.png | 10px | link=]]RouteOfAdministration</span>
 
|0..*
 
|0..*
 
|The way the drugs are used.
 
|The way the drugs are used.
Regel 259: Regel 276:
 
{|
 
{|
 
|-
 
|-
|[[Bestand: List2.png]]||[[#RouteOfAdministrationCodelist|RouteOfAdministrationCodelist]]
+
|[[Bestand: List2.png | link=#RouteOfAdministrationCodelist]]||[[#RouteOfAdministrationCodelist|RouteOfAdministrationCodelist]]
 
|}
 
|}
 
|}
 
|}
Columns Concept and DefinitionCode: hover over the values for more information<BR>
+
Columns Concept and DefinitionCode: hover over the values for more information<!--imHover--><BR>
For explanation of the symbols, please see the legend page [[Bestand:list2.png|link=Legend]]
+
For explanation of the symbols, please see the legend page<!--imLegend--> [[Bestand:list2.png|link=Legend<!--wikiLegend-->]]
  
 
==Example Instances==
 
==Example Instances==
''Only available in Dutch''
+
''Only available in Dutch<!--noTranslation-->''
  
 
{|class="wikitable" width="791px" style= "font-size: 9.5pt;"
 
{|class="wikitable" width="791px" style= "font-size: 9.5pt;"
 
|-style=vertical-align:top;
 
|-style=vertical-align:top;
| style="background-color: #1F497D; width: 10%; color: #FFFFFF; font-weight: bold; "|Soort Middel
+
| style="background-color: #1F497D; width: 10%; "|<font color=#FFFFFF><b>Soort </b></font><font color=#FFFFFF><b>Middel</b></font>
| style="background-color: #1F497D; width: 15%; color: #FFFFFF; font-weight: bold; "|Drugs Gebruik Status
+
| style="background-color: #1F497D; width: 15%; "|<font color=#FFFFFF><b>Drugs Gebruik </b></font><font color=#FFFFFF><b>Status</b></font>
| style="background-color: #1F497D; width: 12%; color: #FFFFFF; font-weight: bold; "|Start datum
+
| style="background-color: #1F497D; width: 12%; "|<font color=#FFFFFF><b>Start datum</b></font>
| style="background-color: #1F497D; width: 11%; color: #FFFFFF; font-weight: bold; "|Stop datum
+
| style="background-color: #1F497D; width: 11%; "|<font color=#FFFFFF><b>Stop datum</b></font>
| style="background-color: #1F497D; width: 17%; color: #FFFFFF; font-weight: bold; "|Toedieningsweg
+
| style="background-color: #1F497D; width: 17%; "|<font color=#FFFFFF><b>Toedieningsweg</b></font>
| style="background-color: #1F497D; width: 16%; color: #FFFFFF; font-weight: bold; "|Hoeveelheid
+
| style="background-color: #1F497D; width: 16%; "|<font color=#FFFFFF><b>Hoeveelheid</b></font>
| style="background-color: #1F497D; width: 20%; color: #FFFFFF; font-weight: bold; "|Toelichting
+
| style="background-color: #1F497D; width: 20%; "|<font color=#FFFFFF><b>Toelichting</b></font>
 
|-style=vertical-align:top;
 
|-style=vertical-align:top;
 
| style="width: 10%; "|XTC
 
| style="width: 10%; "|XTC
Regel 286: Regel 303:
 
| style="width: 20%; "|Op feestjes en in uitgaanscircuit. Vroeger wat meer dan tegenwoordig.
 
| style="width: 20%; "|Op feestjes en in uitgaanscircuit. Vroeger wat meer dan tegenwoordig.
 
|-style=vertical-align:top;
 
|-style=vertical-align:top;
| style="background-color: #1F497D; width: 10%; color: #FFFFFF; font-weight: bold; "|Soort Middel
+
| style="background-color: #1F497D; width: 10%; "|<font color=#FFFFFF><b>Soort </b></font><font color=#FFFFFF><b>Middel</b></font>
| style="background-color: #1F497D; width: 15%; color: #FFFFFF; font-weight: bold; "|Drugs Gebruik Status
+
| style="background-color: #1F497D; width: 15%; "|<font color=#FFFFFF><b>Drugs Gebruik </b></font><font color=#FFFFFF><b>Status</b></font>
| style="background-color: #1F497D; width: 12%; color: #FFFFFF; font-weight: bold; "|Start datum
+
| style="background-color: #1F497D; width: 12%; "|<font color=#FFFFFF><b>Start datum</b></font>
| style="background-color: #1F497D; width: 11%; color: #FFFFFF; font-weight: bold; "|Stop datum
+
| style="background-color: #1F497D; width: 11%; "|<font color=#FFFFFF><b>Stop datum</b></font>
| style="background-color: #1F497D; width: 17%; color: #FFFFFF; font-weight: bold; "|Toedieningsweg
+
| style="background-color: #1F497D; width: 17%; "|<font color=#FFFFFF><b>Toedieningsweg</b></font>
| style="background-color: #1F497D; width: 16%; color: #FFFFFF; font-weight: bold; "|Hoeveelheid
+
| style="background-color: #1F497D; width: 16%; "|<font color=#FFFFFF><b>Hoeveelheid</b></font>
| style="background-color: #1F497D; width: 20%; color: #FFFFFF; font-weight: bold; "|Toelichting
+
| style="background-color: #1F497D; width: 20%; "|<font color=#FFFFFF><b>Toelichting</b></font>
 
|-style=vertical-align:top;
 
|-style=vertical-align:top;
 
| style="width: 10%; "|Heroïne
 
| style="width: 10%; "|Heroïne
Regel 310: Regel 327:
 
{| class="wikitable" width="60%"  
 
{| class="wikitable" width="60%"  
 
|-style='vertical-align:top; background-color: #E8D7BE;'
 
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2
+
|Valueset OID<!--vsValuesetOID-->: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2
 +
|Binding<!--vsBindingTag-->:
 
|}
 
|}
 
{| class="wikitable"  width="60% "
 
{| class="wikitable"  width="60% "
 
|-style="background-color: #1F497D; color: white; font-weight: bold; "
 
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
+
|Conceptname<!--vsConceptName-->
|Conceptcode
+
|Conceptcode<!--vsConceptCode-->
|Codesystem name||Codesystem OID
+
|Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID-->
|Description
+
|Description<!--vsDescription-->
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Misuses drugs (finding)
 
|Misuses drugs (finding)
|361055000
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=361055000 361055000]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 326: Regel 344:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Has never misused drugs
 
|Has never misused drugs
|228368007
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=228368007 228368007]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 332: Regel 350:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Misused drugs in past (finding)
 
|Misused drugs in past (finding)
|44870007
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=44870007 44870007]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
 
|heeft in het verleden drugs gebruikt
 
|heeft in het verleden drugs gebruikt
 
|}
 
|}
 
 
=== RouteOfAdministrationCodelist===
 
=== RouteOfAdministrationCodelist===
 
{| class="wikitable" width="60%"  
 
{| class="wikitable" width="60%"  
 
|-style='vertical-align:top; background-color: #E8D7BE;'
 
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.3
+
|Valueset OID<!--vsValuesetOID-->: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.3
 +
|Binding<!--vsBindingTag-->:
 
|}
 
|}
 
{| class="wikitable"  width="60% "
 
{| class="wikitable"  width="60% "
 
|-style="background-color: #1F497D; color: white; font-weight: bold; "
 
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
+
|Conceptname<!--vsConceptName-->
|Conceptcode
+
|Conceptcode<!--vsConceptCode-->
|Codesystem name||Codesystem OID
+
|Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID-->
|Description
+
|Description<!--vsDescription-->
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|ORAAL
 
|ORAAL
Regel 380: Regel 398:
 
|Anders
 
|Anders
 
|}
 
|}
 
 
=== TypeOfDrugOrMedicationCodelist===
 
=== TypeOfDrugOrMedicationCodelist===
 
{| class="wikitable" width="60%"  
 
{| class="wikitable" width="60%"  
 
|-style='vertical-align:top; background-color: #E8D7BE;'
 
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1
+
|Valueset OID<!--vsValuesetOID-->: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1
 +
|Binding<!--vsBindingTag-->:
 
|}
 
|}
 
{| class="wikitable"  width="60% "
 
{| class="wikitable"  width="60% "
 
|-style="background-color: #1F497D; color: white; font-weight: bold; "
 
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
+
|Conceptname<!--vsConceptName-->
|Conceptcode
+
|Conceptcode<!--vsConceptCode-->
|Codesystem name||Codesystem OID
+
|Codesystem name<!--vsConceptSystemName-->||Codesystem OID<!--vsConceptSystemOID-->
|Description
+
|Description<!--vsDescription-->
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Heroin (substance)
 
|Heroin (substance)
|387341002
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387341002 387341002]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 400: Regel 418:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Benzodiazepine (substance)
 
|Benzodiazepine (substance)
|372664007
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=372664007 372664007]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 406: Regel 424:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Methadone (substance)
 
|Methadone (substance)
|387286002
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387286002 387286002]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 412: Regel 430:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Hydroxybutyric acid (substance)
 
|Hydroxybutyric acid (substance)
|62821004
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=62821004 62821004]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 418: Regel 436:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Cocaine (substance)
 
|Cocaine (substance)
|387085005
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387085005 387085005]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 424: Regel 442:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Cocaine freebase (substance)
 
|Cocaine freebase (substance)
|229003004
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=229003004 229003004]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 430: Regel 448:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Methylenedioxymethamphetamine (substance)
 
|Methylenedioxymethamphetamine (substance)
|288459003
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=288459003 288459003]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 436: Regel 454:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Amphetamine (substance)
 
|Amphetamine (substance)
|703842006
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=703842006 703842006]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 442: Regel 460:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Cannabis (substance)
 
|Cannabis (substance)
|398705004
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=398705004 398705004]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 448: Regel 466:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Hallucinogenic mushrooms (substance)
 
|Hallucinogenic mushrooms (substance)
|229006007
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=229006007 229006007]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 454: Regel 472:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Lysergic acid diethylamide (substance)
 
|Lysergic acid diethylamide (substance)
|15698006
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=15698006 15698006]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 460: Regel 478:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Ketamine (substance)
 
|Ketamine (substance)
|373464007
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=373464007 373464007]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 466: Regel 484:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Phencyclidine (substance)
 
|Phencyclidine (substance)
|9721008
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=9721008 9721008]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 472: Regel 490:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Methamphetamine (substance)
 
|Methamphetamine (substance)
|387499002
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387499002 387499002]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 478: Regel 496:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Anabolic steroid (substance)
 
|Anabolic steroid (substance)
|111151007
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=111151007 111151007]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 484: Regel 502:
 
|-style="vertical-align:top; "
 
|-style="vertical-align:top; "
 
|Laxative (substance)
 
|Laxative (substance)
|372800002
+
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=372800002 372800002]
 
|SNOMED CT
 
|SNOMED CT
 
|2.16.840.1.113883.6.96
 
|2.16.840.1.113883.6.96
Regel 496: Regel 514:
 
|}
 
|}
  
 
+
==This information model in other releases<!--ftOtherReleases-->==
==More on this information model==
+
<!-- Hieronder wordt een transclude page aangeroepen -->
More technical information and HL7/XML documentation you can find on the Nictiz Art-Decor page about this information model[http://decor.nictiz.nl/art-decor/decor-datasets--zib1bbr-?id=2.16.840.1.113883.2.4.3.11.60.40.3.7.4] <BR>
+
{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.7.4(EN)|2|2015}}
This information model is also available as [[Media:nl.nfu.DrugUse-v1.2.2(2015EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.nfu.DrugUse-v1.2.2(2015EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]]
+
<!-- Tot hier de transclude page -->
==About this information==
+
==Information model references<!--ftReferences-->==
The information in this wikipage is based on ''Registratie aan de bron'' publication 2015 including errata dd. 16-07-2015 <BR>
+
====This information model refers to<!--ftRefersTo-->====
Conditions for use are located on the mainpage [[Bestand:list2.png|link=HCIM_Mainpage]]<BR>
+
:--
This page is generated on 27/09/2017 23:58:56 <BR>
+
====This information model is used in<!--ftReferredBy-->====
 +
:--
 +
==Technical specifications in HL7v3 CDA and HL7 FHIR<!--ftHeader-->==
 +
To exchange information based on health and care information models, additional, more technical specifications are required.<BR>
 +
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:<!--ftReferenceIntro-->
 +
<ul>
 +
<li>HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment<!--ftArtDecorReference--> [http://decor.nictiz.nl/art-decor/decor-scenarios--zib2015bbr-?id=2.16.840.1.113883.2.4.3.11.60.5.4.2.7.4&effectiveDate=2015-04-01T00:00:00&language=en-US&scenariotree=false [[File:artdecor.jpg|16px|link=]]]</li>
 +
<li>HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR<!--ftSimplifierReference--> {{SimplefierLinks|2015}}</li>
 +
</ul>
 +
==Downloads<!--ftDownloadTitle-->==
 +
This information model is also available as [[Media:nl.nfu.DrugUse-v1.2.2(2015EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.nfu.DrugUse-v1.2.2(2015EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]]<!--ftDownloads-->
 +
==About this information<!--ftHeader2-->==
 +
The information in this wikipage is based on<!--ftInfoBase--> ''Registratie aan de bron'' publication 2015 including errata dd. 16-07-2015 <BR>
 +
Conditions for use are located on the mainpage<!--ftConditions--> [[Bestand:list2.png|link=HCIM_Mainpage<!--wikiMainpage-->]]<BR>
 +
This page is generated on 24/12/2018 12:29:22 with ZibExtraction v. 3.0.6932.1989<!--ftDate--> <BR>
 
-----
 
-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2015(EN)]] [[HCIM_Release_2015(EN) |Back to HCIM list ]]</div>
+
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release<!--wikiReleasePage-->_2015(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2015(EN) |Back to HCIM list<!--hdBackToMainPage--> ]]</div>

Huidige versie van 24 dec 2018 om 11:14


Attention!! This is not the most recent version of this information model. You can find the most recent version ''here''.

General information

Name: nl.nfu.DrugUse NL.png
Version: 1.2.2
HCIM Status:Final
Release: 2015
Release status: Published
Release date: 1-4-2015


Back 16.png Back to HCIM list

Metadata

DCM::CoderList Kerngroep Registratie aan de Bron
DCM::ContactInformation.Address *
DCM::ContactInformation.Name *
DCM::ContactInformation.Telecom *
DCM::ContentAuthorList Projectgroep Generieke Overdrachtsgegevens & Kerngroep Registratie aan de Bron
DCM::CreationDate
DCM::DeprecatedDate
DCM::DescriptionLanguage nl
DCM::EndorsingAuthority.Address
DCM::EndorsingAuthority.Name NFU
DCM::EndorsingAuthority.Telecom
DCM::Id 2.16.840.1.113883.2.4.3.11.60.40.3.7.4
DCM::KeywordList drugsgebruik, verdovende middelen, middelen gebruik, drugs
DCM::LifecycleStatus Final
DCM::ModelerList Kerngroep Registratie aan de Bron
DCM::Name nl.nfu.DrugsGebruik
DCM::PublicationDate 1-4-2015
DCM::PublicationStatus Published
DCM::ReviewerList Projectgroep Generieke Overdrachtsgegevens & Kerngroep Registratie aan de Bron
DCM::RevisionDate 16-7-2015
DCM::Superseeds
DCM::Version 1.2.2
HCIM::PublicationLanguage EN

Revision History

Only available in Dutch

Publicatieversie 1.0 (15-02-2013)

Publicatieversie 1.1 (01-07-2013)

Publicatieversie 1.2 (01-04-2015)

ZIB-138 Aanpassingen in SNOMED CT codes en omschrijvingen voor codelijst DrugsGebruikStatusCodelijst n.a.v. review terminologie expert.
ZIB-139 Aanpassingen in SNOMED CT codes en omschrijvingen voor codelijst DrugsOfGeneesmiddelSoortCodelijst n.a.v. review terminologie expert.
ZIB-158 Cardinaliteit SoortMiddel aanpassen in bouwsteen OverdrachtDrugsgebruik
ZIB-161 Het concept Hoeveelheid van bouwsteen OverdrachtDrugsgebruik.
ZIB-167 Bevindingen Concept inrichting Intoxicatie Roken/ Alcohol en Drugs in EZIS.NET
ZIB-224 In de klinische bouwsteen OverdrachtDrugsgebruik, concept SoortMiddel komt tagged value DrugsOfGeneesmiddelSoortCodelijst niet overeen met naam gekoppelde valueset DrugsOfGeneesmiddelSoort.
ZIB-225 In de klinische bouwsteen OverdrachtDrugsgebruik, concept ToedieningsWeg komt tagged value ToedieningsWegCodelijst niet overeen met naam gekoppelde valueset.
ZIB-308 Prefix Overdracht weggehaald bij de generieke bouwstenen
ZIB-312 aanpassing paragraaf 'Concept'
ZIB-313 Aanpassen paragraaf 'Purpose'
ZIB-316 Paragraaf 'Evidence base' wijzigen
ZIB-319 Wijzing paragraaf Constraint

Incl. algemene wijzigingsverzoeken:

ZIB-94 Aanpassen tekst van Disclaimer, Terms of Use & Copyrights
ZIB-154 Consequenties opsplitsing Medicatie bouwstenen voor overige bouwstenen.
ZIB-200 Naamgeving SNOMED CT in tagged values klinische bouwstenen gelijk getrokken.
ZIB-201 Naamgeving OID: in tagged value notes van klinische bouwstenen gelijk getrokken.
ZIB-309 EOI aangepast
ZIB-324 Codelijsten Name en Description beginnen met een Hoofdletter
ZIB-326 Tekstuele aanpassingen conform de kwaliteitsreview kerngroep 2015

Publicatieversie 1.2.1 (22-05-2015)

ZIB-388 De ToedieningswegCodelijst heeft geen "OID: " aanduiding in de onderliggende codelijst.

Publicatieversie 1.2.2 (16-07-2015)

ZIB-418 Vervallen SNOMED CT code in DrugsOfGeneesmiddelSoortCodelijst

Concept

Drugs (or: narcotics, amphetamines, intoxicants, highs, hallucinogenics, illegal substances or dope) is a collective term for drugs and chemical substances with a more or less ‘drugging' (anesthetic, boosting and/or hallucinogenic) effect and which can lead to addiction. Drug [Online] Available at: nl.Wikipedia.org/wiki/drug [Accessed: 11 February 2015].

This building block describes the information asked of the patient about their drug use.

Purpose

Documenting and sharing registration of the drug use, as described in the concept.

Evidence Base

Though this building block can also be used to abuse (the patient’s own) medication, the project group eventually decided to focus on the transfer of information on drug use, as described in the concept.
Seeing as there is a large variety of ways to record the amount of drugs used, we decided that this part is to be entered as free text.

Information Model


#11349#RouteOfAdministrationCodelist#DrugUseStatusCodelist#11356#11342#TypeOfDrugOrMedicationCodelist#11347#11354#11335#11352#11336#11333DrugUse-v1.2.2Model(2015EN).png


Type Id Concept Card. Definition DefinitionCode Reference
Block.png NL-CM:7.4.1 Arrowdown.pngDrugUse Root concept of the DrugUse building block. This concept contains all data elements of the DrugUse building block.
Folder.png NL-CM:7.4.5 Arrowdown.pngObservationOfUse 0..1 Container for ObservationOfUse. This container contains all data elements of the ObservationOfUse container.
TS.png NL-CM:7.4.6 Arrowright.pngStartDate 0..1 The date on which the patient started using.
TS.png NL-CM:7.4.7 Arrowright.pngStopDate 0..1 The date on which the patient quit using
ST.png NL-CM:7.4.8 Arrowright.pngAmount 0..1 The number of units (pills, joints, shots etc.) per day, week, month or year or the frequency of use.
ST.png NL-CM:7.4.9 Arrowright.pngExplanation 0..1 Relevant comments on the drug use.
CD.png NL-CM:7.4.2 Arrowright.pngTypeOfDrugOrMedication 0..1 Type of drug used by the patient.
List2.png TypeOfDrugOrMedicationCodelist
CD.png NL-CM:7.4.3 Arrowright.pngDrugUseStatus 1 Indication stating whether there was any drug use in the past or present.
List2.png DrugUseStatusCodelist
CD.png NL-CM:7.4.4 Arrowright.pngRouteOfAdministration 0..* The way the drugs are used.
List2.png RouteOfAdministrationCodelist

Columns Concept and DefinitionCode: hover over the values for more information
For explanation of the symbols, please see the legend page List2.png

Example Instances

Only available in Dutch

Soort Middel Drugs Gebruik Status Start datum Stop datum Toedieningsweg Hoeveelheid Toelichting
XTC misbruikt drugs 1985 oraal 2x per maand Op feestjes en in uitgaanscircuit. Vroeger wat meer dan tegenwoordig.
Soort Middel Drugs Gebruik Status Start datum Stop datum Toedieningsweg Hoeveelheid Toelichting
Heroïne heeft in het verleden drugs gebruikt 1970 1985 intraveneus 3x per week

Issues

Valuesets

DrugUseStatusCodelist

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2 Binding:
Conceptname Conceptcode Codesystem name Codesystem OID Description
Misuses drugs (finding) 361055000 SNOMED CT 2.16.840.1.113883.6.96 misbruikt drugs
Has never misused drugs 228368007 SNOMED CT 2.16.840.1.113883.6.96 heeft nooit drugs misbruikt
Misused drugs in past (finding) 44870007 SNOMED CT 2.16.840.1.113883.6.96 heeft in het verleden drugs gebruikt

RouteOfAdministrationCodelist

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.3 Binding:
Conceptname Conceptcode Codesystem name Codesystem OID Description
ORAAL 9 G-Standaard Toedieningswegen 2.16.840.1.113883.2.4.4.9 oraal
NASAAL 6 G-Standaard Toedieningswegen 2.16.840.1.113883.2.4.4.9 nasaal (snuiven)
INHALATIE 62 G-Standaard Toedieningswegen 2.16.840.1.113883.2.4.4.9 Inhalatie (roken)
INTRAVENEUS 5 G-Standaard Toedieningswegen 2.16.840.1.113883.2.4.4.9 Intraveneus (spuiten)
Other OTH NullFlavor 2.16.840.1.113883.5.1008 Anders

TypeOfDrugOrMedicationCodelist

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1 Binding:
Conceptname Conceptcode Codesystem name Codesystem OID Description
Heroin (substance) 387341002 SNOMED CT 2.16.840.1.113883.6.96 Heroïne
Benzodiazepine (substance) 372664007 SNOMED CT 2.16.840.1.113883.6.96 Benzodiazepine
Methadone (substance) 387286002 SNOMED CT 2.16.840.1.113883.6.96 Methadon
Hydroxybutyric acid (substance) 62821004 SNOMED CT 2.16.840.1.113883.6.96 GHB
Cocaine (substance) 387085005 SNOMED CT 2.16.840.1.113883.6.96 Cocaïne
Cocaine freebase (substance) 229003004 SNOMED CT 2.16.840.1.113883.6.96 Crack, base coke
Methylenedioxymethamphetamine (substance) 288459003 SNOMED CT 2.16.840.1.113883.6.96 MDMA
Amphetamine (substance) 703842006 SNOMED CT 2.16.840.1.113883.6.96 Amfetamine, speed
Cannabis (substance) 398705004 SNOMED CT 2.16.840.1.113883.6.96 Cannabis, wiet marihuana, hasj
Hallucinogenic mushrooms (substance) 229006007 SNOMED CT 2.16.840.1.113883.6.96 Paddos
Lysergic acid diethylamide (substance) 15698006 SNOMED CT 2.16.840.1.113883.6.96 LSD
Ketamine (substance) 373464007 SNOMED CT 2.16.840.1.113883.6.96 Ketamine
Phencyclidine (substance) 9721008 SNOMED CT 2.16.840.1.113883.6.96 PCP
Methamphetamine (substance) 387499002 SNOMED CT 2.16.840.1.113883.6.96 Crystal meth, methamfetamine
Anabolic steroid (substance) 111151007 SNOMED CT 2.16.840.1.113883.6.96 Anabole steroïde
Laxative (substance) 372800002 SNOMED CT 2.16.840.1.113883.6.96 Laxans
Other OTH NullFlavor 2.16.840.1.113883.5.1008 Anders

This information model in other releases

Information model references

This information model refers to

--

This information model is used in

--

Technical specifications in HL7v3 CDA and HL7 FHIR

To exchange information based on health and care information models, additional, more technical specifications are required.
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:

  • HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment Artdecor.jpg
  • HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR Fhir.png

Downloads

This information model is also available as pdf file PDF.png or as spreadsheet Xlsx.png

About this information

The information in this wikipage is based on Registratie aan de bron publication 2015 including errata dd. 16-07-2015
Conditions for use are located on the mainpage List2.png
This page is generated on 24/12/2018 12:29:22 with ZibExtraction v. 3.0.6932.1989


Back 16.png Back to HCIM list